A research team at the VIB-KU Leuven Center for Microbiology has developed a novel screening method to identify antimicrobial properties of volatile substances. With this assay, they tested the vapour-phase-mediated activity of 175 essential oils (EOs) and 37 EO components. Approximately half of them proved active against the most drug-resistant type of Candida. In a context of fungi showing increasing drug resistance, these findings may be useful in both medical and agricultural applications.
The research project, led by prof. Patrick Van Dijck, is rooted in the growing problem of antifungal drug resistance. Candida cells, for example, are quickly becoming tolerant to fluconazole, the most-used antifungal drug. Next to exploring experimental new techniques, scientists also seek to repurpose existing substances. Plant essential oils (EOs), metabolites obtained by steam distillation or cold citrus peel pressing, may offer interesting opportunities: they are made up of compounds that help protect the plant against microbial or herbivore attacks.
Identifying EOs and their compounds
In the VIB-KU Leuven Center for Microbiology, Adam Feyaerts gathered a collection of 175 different EOs, constituting a collection of over one thousand different small molecules. The aim was to identify biologically active compounds present in these complex mixtures. They therefore developed a new class of assay that allowed to identify new volatile substances with antifungal activities over a distance.
Prof. Patrick Van Dijck (VIB-KU Leuven): “We screened our whole collection of EOs for vapor-phase mediated antifungal activity against two human fungal pathogens, Candida albicans and Candida glabrata. Interestingly, we found that approximately half of the EOs and their compounds had vapour-phase-mediated activity against bothCandida species. Surprisingly, C. glabrata, the most drug-resistant species of the two was on average even more susceptible. In contrast, none of the currently used antifungals showed any vapour-phase-mediated activity.”
Numerous potential applications
This is now the first simple test to look for the vapor-phase-mediated antimicrobial activity of molecules. The same assay could also be used to test other biological activity. And although these findings still have to be confirmed in clinical trials, potential applications are numerous.
Co-author Adam Feyaerts (VIB-KU Leuven): “Our findings are for instance a starting point for the development of molecules that could also be used in vaporizers. After all, volatiles can access otherwise hard to reach areas. Think of possibilities such as maintaining hygiene in hospitals or treat patients with lung infections. There are agricultural options too, such as preventing post-harvest contamination or protecting crops against pests.”
The Latest on: Antifungal drug resistance
- Drug Resistance Could Soon Kill More People Each Year Than Cancer, UN Warns on November 13, 2018 at 12:14 pm
The United Nations warned today that deaths attributed to resistance ... fungal infections -- could surpass annual fatalities from cancer in a "global health emergency." To kick off World ... […]
- £500,000 grant could lead to new antibiotic to combat superbugs on November 13, 2018 at 10:38 am
The teixobactin project complements our other programs for development of new antibiotics for multidrug resistant bacterial and fungal diseases." The next step in the research will be the production o... […]
- SCYNEXIS Reports Third Quarter 2018 Financial Results and Provides Company Update on November 13, 2018 at 5:05 am
With SCYNEXIS's U.S. Food and Drug Administration (FDA)-endorsed Phase ... Patients with no therapeutic options for invasive fungal infections continue to enroll in SCYNEXIS's ibrexafungerp ... […]
- Antimicrobial resistance 'global health emergency': UN on November 13, 2018 at 2:36 am
Deaths due to antimicrobial resistance (AMR ... defines antimicrobials as drugs which prevent and treat parasitic, bacterial, viral and fungal infections. However, overuse by health practitioners ... […]
- Roach: Candida glabrata may require more focused treatment on November 12, 2018 at 7:06 pm
C. glabrata is more resistant to antifungal drugs, especially fluconazole (Diflucan), than C. albicans. So, if you had persistent symptoms, you might be treated with higher doses of fluconazole, a rel... […]
- World Antibiotic Awareness Week on November 11, 2018 at 8:04 pm
viral and fungal infections. Antibiotic resistance is the ability of bacteria to survive treatment with antibiotics. Thus, AMR is the general term for drug resistance in microbes. It occurs naturally ... […]
- Fake drugs: The global industry putting your life at risk on November 4, 2018 at 7:35 pm
A more discreet kind of substandard medicine — say, an antibiotic without enough active ... the medicine had contaminants that caused fungal meningitis. The batch of medicine, originating ... […]
- Off-patent drug appears promising as broad-spectrum antifungal on October 31, 2018 at 10:41 am
"There are currently only three major classes of antifungal drugs used in the clinic and several pathogenic fungi are resistant to them, so there is an urgent need to identify compounds that have ... […]
- Multidrug-Resistant Aspergillus fumigatus on the Rise on October 30, 2018 at 5:09 pm
A drug-resistant strain of the deadly environmental mold Aspergillus fumigatus is emerging in the United States, according to a new study. According to the CDC, the strain, which is resistant to all c... […]
via Google News and Bing News